MCID: DSS008
MIFTS: 53

Disease of Mental Health

Categories: Mental diseases, Neuronal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Disease of Mental Health

Summaries for Disease of Mental Health

MedlinePlus: 41 What is mental health? Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act as we cope with life. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, from childhood and adolescence through adulthood and aging. What are mental disorders? Mental disorders are serious conditions which can affect your thinking, mood, and behavior. They may be occasional or long-lasting. They can affect your ability to relate to others and function each day. Mental disorders are common; more than half of all Americans will be diagnosed with one at some time in their life. But there are treatments. People with mental disorders can get better, and many of them recover completely. Why is mental health important? Mental health is important because it can help you to: Cope with the stresses of life Be physically healthy Have good relationships Make meaningful contributions to your community Work productively Realize your full potential Your mental health is also important because it can affect your physical health. For example, mental disorders can raise your risk for physical health problems such as stroke, type 2 diabetes, and heart disease. What can affect my mental health? There are many different factors that can affect your mental health, including: Biological factors, such as genes or brain chemistry Life experiences, such as trauma or abuse Family history of mental health problems Your lifestyle, such as diet, physical activity, and substance use You can also affect your mental health by taking steps to improve it, such as doing meditation, using relaxation techniques, and practicing gratitude. Can my mental health change over time? Over time, your mental health can change. For example, you may be dealing with a difficult situation, such as trying to manage a chronic illness, taking care of an ill relative, or facing money problems. The situation may wear you out and overwhelm your ability to cope with it. This can worsen your mental health. On the other hand, getting therapy may improve your mental health. What are the signs that I might have a mental health problem? When it comes to your emotions, it can be hard to know what is normal and what is not. There are warning signs that you may have a mental health problem, including: A change in your eating or sleeping habits Withdrawing from the people and activities you enjoy Having low or no energy Feeling numb or like nothing matters Having unexplained aches and pains Feeling helpless or hopeless Smoking, drinking, or using drugs more than usual Feeling unusually confused, forgetful, angry, upset, worried, or scared Having severe mood swings that cause problems in your relationships Having thoughts and memories that you can't get out of your head Hearing voices or believing things that are not true Thinking of harming yourself or others Not being able to perform daily tasks like taking care of your kids or getting to work or school What should I do if I think I have a mental health problem? If you think that you may have a mental health problem, get help. Talk therapy and/or medicines can treat mental disorders. If you don't know where to start, contact your primary care provider.

MalaCards based summary: Disease of Mental Health, also known as mental health, is related to post-traumatic stress disorder and bipolar disorder, and has symptoms including lethargy, agitation and forgetful. An important gene associated with Disease of Mental Health is BDNF-AS (BDNF Antisense RNA). The drugs Acetaminophen and Donepezil have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and prefrontal cortex.

Disease Ontology: 11 A disease that involves a psychological or behavioral pattern generally associated with subjective distress or disability that occurs in an individual, and which are not a part of normal development or culture.

Wikipedia: 75 Mental health encompasses emotional, psychological, and social well-being, influencing cognition,... more...

Related Diseases for Disease of Mental Health

Diseases related to Disease of Mental Health via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1555)
# Related Disease Score Top Affiliating Genes
1 post-traumatic stress disorder 33.3 MIR124-1 H2AC18 BDNF
2 bipolar disorder 33.0 PRODH MIR132 KDM4C BDNF APOE
3 attention deficit-hyperactivity disorder 33.0 SERPINA3 PRODH MIR24-1 H2AC18 EPRS1 BDNF
4 substance abuse 32.9 SERPINA3 PRODH MIR9-1 H2AC18 CCR6 BDNF
5 psychotic disorder 32.7 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR21
6 schizophrenia 32.7 SERPINA3 PRODH MIR9-1 MIR132 BLOC1S1 BDNF-AS
7 learning disability 32.7 PRODH MIR9-1 H2AC18 BDNF
8 mood disorder 32.6 SERPINA3 PRODH MIR9-1 MIR24-1 MIR132 MIR124-1
9 alcohol use disorder 32.6 SERPINA3 PRODH KDM4C H2AC18 CCR6 BDNF
10 pervasive developmental disorder 32.6 PRODH MIR9-1 MIR24-1 MIR132 KDM4C H2AC18
11 generalized anxiety disorder 32.5 PRODH H2AC18 BDNF
12 specific developmental disorder 32.5 SERPINA3 PRODH MIR9-1 MIR24-1 MIR21 MIR132
13 sleep disorder 32.5 H2AC18 BDNF APOE
14 dementia, lewy body 32.4 SERPINA3 MIR9-1 MIR22 MIR132 H2AC18 BDNF
15 schizoaffective disorder 32.4 SERPINA3 PRODH BDNF
16 social phobia 31.9 SERPINA3 PRODH BDNF
17 nutritional deficiency disease 31.9 SERPINA3 H2AC18 CCR6 BDNF
18 parkinson disease, late-onset 31.9 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR21
19 body mass index quantitative trait locus 11 31.8 SERPINA3 PRODH MIR9-1 MIR22 MIR21 MIR142
20 multiple sclerosis 31.7 MIR21 MIR142 MIR132 CCR6 BDNF APOE
21 agoraphobia 31.7 PRODH MIR22 BDNF
22 cardiovascular system disease 31.7 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR21
23 immune deficiency disease 31.7 SERPINA3 MIR9-1 MIR24-1 MIR22 MIR21 MIR142
24 heart disease 31.6 SERPINA3 PRODH MIR24-1 MIR21 MIR142 H2AC18
25 phobia, specific 31.6 PRODH H2AC18 BDNF
26 chronic fatigue syndrome 31.6 SERPINA3 MIR142 H2AC18 CCR6 BDNF
27 gastrointestinal system disease 31.6 SERPINA3 MIR9-1 MIR24-1 MIR22 MIR21 MIR142
28 substance dependence 31.6 SERPINA3 H2AC18 BDNF
29 mild cognitive impairment 31.6 SERPINA3 MIR22 MIR142 MIR132 BDNF APOE
30 alzheimer disease, familial, 1 31.6 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR21
31 pulmonary disease, chronic obstructive 31.6 SERPINA3 MIR21 MIR142 H2AC18 CCR6
32 dermatitis, atopic 31.5 SERPINA3 MIR21 MIR142 CCR6 BDNF
33 speech and communication disorders 31.5 SERPINA3 PRODH BDNF APOE
34 skin disease 31.5 SERPINA3 PRODH MIR9-1 MIR24-1 MIR21 MIR142
35 respiratory failure 31.5 SERPINA3 MIR21 MIR142 H2AC18 CCR6
36 physical disorder 31.5 SERPINA3 PRODH MIR9-1 MIR24-1 MIR21 MIR142
37 cerebrovascular disease 31.5 SERPINA3 MIR9-1 MIR22 MIR21 MIR142 MIR132
38 fetal alcohol syndrome 31.4 MIR9-1 KDM4C H2AC18 BDNF
39 lung disease 31.4 SERPINA3 MIR21 MIR142 H2AC18 EPRS1 CCR6
40 migraine with or without aura 1 31.4 SERPINA3 H2AC18 BDNF APOE
41 type 2 diabetes mellitus 31.4 SERPINA3 PRODH MIR9-1 MIR22 MIR21 MIR142
42 severe covid-19 31.3 SERPINA3 MIR21 CCR6
43 lipid metabolism disorder 31.3 SERPINA3 MIR21 H2AC18 CCR6 APOE
44 huntington disease 31.3 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR132
45 subjective cognitive decline 31.3 SERPINA3 BDNF APOE
46 amyotrophic lateral sclerosis 1 31.3 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR142
47 arteriosclerosis 31.3 MIR24-1 MIR22 MIR21 MIR142 APOE
48 arteries, anomalies of 31.3 SERPINA3 MIR9-1 MIR24-1 MIR22 MIR21 MIR142
49 eye disease 31.2 SERPINA3 PRODH MIR9-1 MIR22 MIR21 MIR142
50 lipoprotein quantitative trait locus 31.2 SERPINA3 MIR24-1 MIR22 MIR21 MIR142 MIR132

Graphical network of the top 20 diseases related to Disease of Mental Health:



Diseases related to Disease of Mental Health

Symptoms & Phenotypes for Disease of Mental Health

UMLS symptoms related to Disease of Mental Health:


lethargy; agitation; forgetful; decrease in appetite; nervousness; feeling jittery; symptoms; alexithymia; increased libido; numbness; psychiatric symptom; hallucinations, auditory; hallucinations, visual; numbness localized; feeling detached; feeling strange; feeling weightless; floating feeling; dejection emotional; depressed reaction; hallucinations, sensory; restless sleep; difficulty sleeping; excitability; depression aggravated; agitation mental; numb mouth; opiate withdrawal symptoms; clouded consciousness; trembling inside; sluggishness

Drugs & Therapeutics for Disease of Mental Health

Drugs for Disease of Mental Health (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 430)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetaminophen Approved Phase 4 103-90-2 1983
2
Donepezil Approved Phase 4 120014-06-4 3152
3
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
4
Modafinil Approved, Investigational Phase 4 68693-11-8 4236
5
Metamfetamine Approved, Illicit, Withdrawn Phase 4 537-46-2 10836
6
Fluvoxamine Approved, Investigational Phase 4 54739-18-3 5324346 3404
7
Amitriptyline Approved Phase 4 50-48-6 2160
8
Norepinephrine Approved Phase 4 51-41-2 439260
9
Ketamine Approved, Vet_approved Phase 4 6740-88-1, 1867-66-9 3821
10
Duloxetine Approved Phase 4 136434-34-9, 116539-59-4 60835
11
Histamine Approved, Investigational Phase 4 51-45-6 774
12
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
13
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
14
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
15
Cyproheptadine Approved Phase 4 129-03-3 2913
16
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
17
Cinnarizine Approved, Investigational Phase 4 298-57-7 1547484
18
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
19
Metformin Approved Phase 4 1115-70-4, 657-24-9 4091
20
Perphenazine Approved Phase 4 58-39-9 4748
21
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
22
Simvastatin Approved Phase 4 79902-63-9 54454
23
Ferrous succinate Approved Phase 4 10030-90-7
24
Sibutramine Approved, Illicit, Investigational, Withdrawn Phase 4 106650-56-0 5210
25
Acetylcysteine Approved, Investigational Phase 4 616-91-1 581 12035
26
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
27
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
28
Sodium oxybate Approved Phase 4 502-85-2 23663870
29
Losartan Approved Phase 4 114798-26-4 3961
30
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 11128-99-7, 4474-91-3 172198
31
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
32
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
33
Bupropion Approved Phase 4 31677-93-7, 34841-39-9, 34911-55-2 444
34
Dexmedetomidine Approved, Experimental, Vet_approved Phase 4 86347-14-0, 113775-47-6 68602 5311068
35
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
36
Exenatide Approved, Investigational Phase 4 141758-74-9 45588096
37
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
38
Polyestradiol phosphate Approved Phase 4 28014-46-2
39
Tocopherol Approved, Investigational Phase 4 1406-66-2
40 Coconut Approved Phase 4
41
Iodine Approved, Investigational Phase 4 7553-56-2 807
42
Glucagon Approved Phase 4 16941-32-5 16133228 16186314
43
Liraglutide Approved Phase 4 204656-20-2 44147092 16134956
44
Ethanol Approved Phase 4 64-17-5 702
45
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
46
Sertraline Approved Phase 4 79617-96-2 68617
47
Citalopram Approved Phase 4 59729-32-7, 59729-33-8 2771
48
Galantamine Approved Phase 4 357-70-0, 1953-04-4 9651
49
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
50
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1

Interventional clinical trials:

(show top 50) (show all 3064)
# Name Status NCT ID Phase Drugs
1 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148535 Phase 4 Lithium Carbonate;lithium carbonate combined with SSRI antidepressant treatment
2 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148509 Phase 4 risperidone;aripiprazole;bupropion
3 Comparison of Paracetamol and Dexketoprofen Trometamol on Headache Treatment After Electroconvulsive Treatment Unknown status NCT03830398 Phase 4 Paracetamol;Deksketoprofen trometamol;Placebo
4 Determination of ED50 and ED95 of Single Bolus Dexmedetomidine in General Anesthesia Patients to Produce Acceptable Hemodynamic Outcomes Unknown status NCT03655847 Phase 4 Dexmedetomidine
5 Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder Unknown status NCT03857581 Phase 4 Clozapine;Olanzapine
6 Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 3-year Follow-up Unknown status NCT03090503 Phase 4 Aripiprazole;Risperidone
7 Clinical Utility of Pharmacogenomics of Psychotropic Medications Unknown status NCT03907124 Phase 4 Genetically-guided treatment with FDA-approved psychotropic drugs;Treatment as usual (TAU)
8 Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: a Randomized Comparison of Aripiprazole and Risperidone Over 3 Years Unknown status NCT03883204 Phase 4 Aripiprazole;Risperidone
9 Determining the Efficacy and Tolerance of Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry Unknown status NCT00986167 Phase 4 Quetiapine XR
10 Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 1-year Follow-up Unknown status NCT02532491 Phase 4 Aripiprazole;Risperidone
11 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis- An Investigator-initiated, Phase IV, Randomised Double-blind Multi-centre Trial of the Benefits and Harms of Aripiprazole Versus Quetiapine in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
12 Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study Unknown status NCT02836743 Phase 4 Circadin;Placebo
13 Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs Unknown status NCT01182012 Phase 4
14 The Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults: A Pilot Study Completed NCT00482001 Phase 4 donepezil;Placebo (cornstarch)
15 Study on the Effect of Combined Oral Contraceptive Therapy on Female Sexuality, Body Image and Mental Health Completed NCT02613039 Phase 4 Combined Estrogen-Progestin Oral Contraceptives
16 A DOUBLE-BLIND PILOT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PROVIGIL® (MODAFINIL) AT FIXED/FLEXIBLE DOSES, IN CONJUNCTION WITH IDENTIFIED SSRIs FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH MILD TO MODERATE DEPRESSION WITH ATTENDANT SYMPTOMS OF SLEEPINESS AND FATIGUE Completed NCT00208715 Phase 4 Provigil
17 The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff Completed NCT01462058 Phase 4 Placebo
18 Memory and Mental Health in Aging: Psychopharmacological Augmentation of Memory Training in Older Adults Completed NCT02988908 Phase 4 Donepezil;Placebos
19 Retrospective Review of Ketamine Assisted Psychotherapy Program on Mental Health at Field Trip Health Centres in North America Completed NCT05604794 Phase 4
20 Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana Completed NCT02593734 Phase 4 olanzapine;risperidone;amitryptaline;fluoxetine
21 Brain Imaging and Mental Disorders of Aging Intervention Completed NCT00267163 Phase 4 donepezil;Placebo
22 Efficacy of Exposure and Response Prevention(ERP) and SSRIs, and Its Predictors in Obsessive-Compulsive Disorder Completed NCT02022709 Phase 4 Fluoxetine;Sertraline;Paroxetine;Citalopram;Fluvoxamine
23 A Double-Blind Placebo-Controlled Study of Combination Therapy in Children With ADHD Completed NCT01940978 Phase 4 Methylphenidate ER;Cyproheptadine
24 Naltrexone Treatment of Alcohol Abuse in Schizophrenia Completed NCT00145847 Phase 4 Naltrexone or Placebo
25 Post-marketing Clinical Study on PAXIL Tablet in Patients With Depression or Depressive Mood - A Study on Combination of PAXIL Tablet and Benzodiazepines Completed NCT00259883 Phase 4 paroxetine
26 Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans Completed NCT00288782 Phase 4 Mirtazapine
27 Preparing Those With Significant and Persistent Mental Illness to Quit Smoking Completed NCT01783912 Phase 4 Nicotine Patch
28 Therapeutic Effect Between Quetiapine and Haloperidol on the Treatment of Methamphetamine - Induced Psychosis Completed NCT01939093 Phase 4 Diazepam;Stugeron
29 A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis Completed NCT04292223 Phase 4 Pimavanserin
30 Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT) Completed NCT00806234 Phase 4 Aripiprazole or Perphenazine;Metformin;Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine
31 An Open, Multicenter, Non-Comparative Study To Assess The Efficacy And Tolerability Of Intramuscular Ziprasidone Followed By Oral Ziprasidone In Patients With Acute Psychosis Completed NCT00644800 Phase 4 Ziprasidone
32 Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol IM Injection for Treatment of Acute Psychotic Agitation in Schizophrenia Completed NCT00859872 Phase 4 risperidone oral solution;haloperidol
33 A Single-arm Evaluation of the Safety of Paliperidone Extended-Release (ER) in Subjects With Schizophrenia or Schizoaffective Disorder With Hepatic Disease Completed NCT00535145 Phase 4 Treatment as usual (TAU), Paliperidone ER
34 A Phase IV STudy of the Effectiveness of Quetiapine Extended Release 600mg Once a Day to Control the Symptoms of Manic Phase of Bipolar Disorder. Completed NCT00521365 Phase 4 Quetiapine 600mg
35 Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g Completed NCT00558454 Phase 4 Iron
36 Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis: A Randomised, Double Blind, Placebo-Controlled Treatment Trial Completed NCT00396643 Phase 4 Omega 3 fatty acids
37 Phase IV Study of the Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II) Completed NCT02305823 Phase 4 Aripiprazole;Quetiapine;Ziprasidone
38 Cannabis and Schizophrenia: Effects of Clozapine Completed NCT00498550 Phase 4 Clozapine;Treatment as usual
39 Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI): A Pilot Study Completed NCT00453804 Phase 4 injectable naltrexone;oral naltrexone
40 Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial Completed NCT00453609 Phase 4 long-lasting injectable naltrexone
41 Antipsychotic Discontinuation in Alzheimer's Disease Completed NCT00417482 Phase 4 risperidone
42 Is Premorbid Functioning a Predictor of Outcome in Patients With Early Onset Psychosis Treated With Risperdal Consta? Completed NCT00369239 Phase 4 risperidone long acting injectable
43 Single-arm, Open-label and Multicenter Phase IV Study: Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode Psychosis - a Pilot Study Completed NCT00511277 Phase 4 Seroquel®
44 The Cognitive Effects of Risperidone and Olanzapine Completed NCT00108368 Phase 4 Risperidone;Olanzapine
45 The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder Completed NCT00044187 Phase 4 Sibutramine
46 Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) Completed NCT00043849 Phase 4 Quetiapine
47 Interventions for Cardiovascular Disease: "Real-World" Effectiveness of Combined Pharmacotherapy and Behavioural Counseling for Smoking Cessation Completed NCT01623505 Phase 4 Champix;Transdermal Nicoderm patch combined with gum or inhaler;Transdermal Nicoderm patch
48 A Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adult Subjects With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone) Completed NCT03568500 Phase 4 Aripiprazole;Olanzapine;Quetiapine;Risperidone
49 Pimozide Augmentation of Clozapine in Schizophrenia Completed NCT00158223 Phase 4 Pimozide;Placebo
50 Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia Completed NCT00156715 Phase 4 Quetiapine

Search NIH Clinical Center for Disease of Mental Health

Cochrane evidence based reviews: mental disorders

Genetic Tests for Disease of Mental Health

Anatomical Context for Disease of Mental Health

Organs/tissues related to Disease of Mental Health:

MalaCards : Brain, Heart, Prefrontal Cortex, Pituitary, Eye, Spinal Cord, Breast

Publications for Disease of Mental Health

Articles related to Disease of Mental Health:

(show top 50) (show all 30003)
# Title Authors PMID Year
1
Mental Health Chatbot for Young Adults With Depressive Symptoms During the COVID-19 Pandemic: Single-Blind, Three-Arm Randomized Controlled Trial. 41
36355633 2022
2
Mediators of measurement-based care implementation in community mental health settings: results from a mixed-methods evaluation. 41
36271404 2022
3
The Effect of Healthy Lifestyle Changes on Work Ability and Mental Health Symptoms: A Randomized Controlled Trial. 41
36293787 2022
4
Childhood Abuse and Neglect, Exposure to Domestic Violence and Sibling Violence: Profiles and Associations With Sociodemographic Variables and Mental Health Indicators. 62
35445607 2023
5
Synaptic plasticity and mental health: methods, challenges and opportunities. 62
35810199 2023
6
"Don't Just Study our Distress, Do Something": Implementing and Evaluating a Modified Stepped-Care Model for Health Care Worker Mental Health During the COVID-19 Pandemic. 62
35854421 2023
7
The (un)learning of social functions and its significance for mental health. 62
36216722 2022
8
Mental Health before and during the COVID-19 Pandemic: The Role of Partnership and Parenthood Status in Growing Disparities between Types of Families. 62
35837870 2022
9
Competing against COVID-19: what about the mental health problems of athletes with disabilities? 62
34961402 2022
10
Associations among Self-Reported Mental Health, Physical Activity, and Diet during the COVID-19 Pandemic. 62
35234099 2022
11
Prevalence of parental mental health conditions among children aged 0-16 years in Denmark: A nationwide register-based cross-sectional study. 62
34609273 2022
12
Mental health consequences of COVID-19 pandemic among college students and coping approaches adapted by higher education institutions: A scoping review. 62
35665095 2022
13
Measuring the quality of mental health services from the patient perspective in China: psychometric evaluation of the Chinese version of the World Health Organization responsiveness performance questionnaire. 62
35289731 2022
14
Insomnia and poor sleep quality during peripartum: a family issue with potential long term consequences on mental health. 62
33267621 2022
15
You're carrying so many people's stories: vicarious trauma among fly-in fly-out mental health service providers in Canada. 62
35195506 2022
16
Acute relationships between mental health and cognitive function during the COVID-19 pandemic: Longitudinal evidence from middle-aged and older US adults. 62
35434675 2022
17
Adolescent Mental Health and Family Economic Hardships: The Roles of Adverse Childhood Experiences and Family Conflict. 62
35997913 2022
18
Daily stressors and mental health following disaster: A school-based assessment of adolescent disaster survivors in China and Nepal. 62
36067255 2022
19
Idioms of resilience: Mental health and migration in India. 62
34461755 2022
20
Antibiotics and mental health: The good, the bad and the ugly. 62
35819136 2022
21
Characteristics of the ideal healthcare services to meet adolescents' mental health needs: A qualitative study of adolescents' perspectives. 62
36074720 2022
22
Factors associated with prolonged episodes of mechanical restraint in mental health hospitalization units in Andalusia. 62
35088924 2022
23
The impact of the COVID-19 pandemic on the mental health of women seeking treatment for postpartum depression. 62
34882058 2022
24
How does the British public understand mental health? A qualitative analysis of open-text responses. 62
34694185 2022
25
Sex-related differences in violence exposure, neural reactivity to threat, and mental health. 62
36030316 2022
26
Medical students' perception towards mental health recovery: a descriptive qualitative study. 62
35894690 2022
27
Mental health symptoms 1 year after the COVID-19 outbreak in Spain: The role of pre-existing mental disorders and their type. 62
36058361 2022
28
Self-reported mental health symptoms, quality of life and coping strategies in French health sciences students during the early stage of the COVID-19 pandemic: An online survey. 62
34625216 2022
29
Differential Impact of COVID-19 on the Use of Tele-mental Health Among Veterans Living in Urban or Rural Areas. 62
35652189 2022
30
Sleep quality of Singapore residents: findings from the 2016 Singapore mental health study. 62
35243325 2022
31
Outdoor Community Ambulation Interventions to Improve Physical and Mental Health in Older Adults: A Systematic Review and Meta-Analysis. 62
35418512 2022
32
Practitioner and researcher perspectives on the utility of ecological momentary assessment in mental health care: A survey study. 62
36193339 2022
33
Association of Mental Health Burden With Prenatal Cannabis Exposure From Childhood to Early Adolescence: Longitudinal Findings From the Adolescent Brain Cognitive Development (ABCD) Study. 62
36094599 2022
34
Investigating the phenotypic and genetic associations between personality traits and suicidal behavior across major mental health diagnoses. 62
35146571 2022
35
A time for self-care? Frontline health workers' strategies for managing mental health during the COVID-19 pandemic. 62
34913042 2022
36
Associations Between Changes in Loneliness and Social Connections, and Mental Health During the COVID-19 Pandemic: The Women's Health Initiative. 62
34915558 2022
37
Factors associated with work performance and mental health of healthcare workers during pandemics: a systematic review and meta-analysis. 62
34056663 2022
38
Correction to: Families in the COVID‑19 pandemic: parental stress, parent mental health and the occurrence of adverse childhood experiences-results of a representative survey in Germany. 62
34159498 2022
39
Australian Aboriginal and Torres Strait Islander people at risk of declining mental health due to failure to attend for referred follow-up mental health appointments during COVID-19. 62
36070004 2022
40
Should I write about mental health on my med school app? Examining medical school admissions committee members' biases regarding mental health conditions. 62
35900355 2022
41
The role of self-compassion in the mental health of adults with ADHD. 62
35334113 2022
42
Mental health problems and risk assessment in football players infected with SARS-CoV-2: a cross-sectional study. 62
35191288 2022
43
Mental health nursing and autism: I am a mental health nurse so why did it take me so long to realize I'm autistic? 62
33866640 2022
44
Probable COVID-19 infection is associated with subsequent poorer mental health and greater loneliness in the UK COVID-19 Mental Health and Wellbeing study. 62
36460665 2022
45
The mental health impact of COVID-19-related stressors among treatment-seeking trauma-exposed veterans. 62
36065487 2022
46
Association of sleep with mental health in Chinese high school students: a cross-sectional study. 62
35879019 2022
47
A nation-wide Swedish study of opioid analgesic prescribing patterns during pregnancy and associated preexisting mental health conditions. 62
33441038 2022
48
Food Insufficiency, Adverse Childhood Events and Mental Health: Results of the Singapore Mental Health Study 2016. 62
36451283 2022
49
Self-reported fears and mental health in elementary school children across Europe. 62
34125282 2022
50
The Perfect Storm: A Developmental-Sociocultural Framework for the Role of Social Media in Adolescent Girls' Body Image Concerns and Mental Health. 62
35841501 2022

Variations for Disease of Mental Health

Expression for Disease of Mental Health

Search GEO for disease gene expression data for Disease of Mental Health.

Pathways for Disease of Mental Health



Pathways directly related to Disease of Mental Health:

# Pathway Source
1 Defective MAOA causes BRUNS Reactome 66

GO Terms for Disease of Mental Health

Cellular components related to Disease of Mental Health according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 RISC complex GO:0016442 9.47 MIR9-1 MIR24-1 MIR22 MIR21 MIR142 MIR132
2 extracellular vesicle GO:1903561 9.35 MIR24-1 MIR22 MIR21 APOE

Biological processes related to Disease of Mental Health according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 miRNA-mediated gene silencing GO:0035195 9.73 MIR9-1 MIR24-1 MIR22 MIR21 MIR142 MIR132
2 negative regulation of endothelial cell proliferation GO:0001937 9.62 MIR22 MIR21 APOE
3 negative regulation of blood vessel endothelial cell migration GO:0043537 9.46 MIR24-1 MIR132 APOE
4 negative regulation of NIK/NF-kappaB signaling GO:1901223 9.43 MIR9-1 MIR21 MIR132
5 miRNA-mediated gene silencing by inhibition of translation GO:0035278 8.92 MIR9-1 MIR24-1 MIR21 MIR132

Molecular functions related to Disease of Mental Health according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mRNA base-pairing translational repressor activity GO:1903231 9.1 MIR9-1 MIR24-1 MIR22 MIR21 MIR142 MIR132

Sources for Disease of Mental Health

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....